The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Hemangioma is the birthmark or benign tumors of infancy that occurs due to an abnormal collection of blood vessels. This occurs in 5-10% of infants worldwide.
The global Hemangioma market was valued at US$ 1925 million in 2023 and is anticipated to reach US$ 4210.3 million by 2030, witnessing a CAGR of 11.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hemangioma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemangioma.
Report Scope
The Hemangioma market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemangioma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemangioma companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Akrimax
AstraZeneca
Novartis
Cutting Edge Laser Technologies
Pfizer
Pierre Fabre
Segment by Type
Medical Therapy
Laser Therapy
Surgery
Other
Segment by Application
Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemangioma companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hemangioma is the birthmark or benign tumors of infancy that occurs due to an abnormal collection of blood vessels. This occurs in 5-10% of infants worldwide.
The global Hemangioma market was valued at US$ 1925 million in 2023 and is anticipated to reach US$ 4210.3 million by 2030, witnessing a CAGR of 11.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hemangioma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemangioma.
Report Scope
The Hemangioma market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemangioma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemangioma companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Akrimax
AstraZeneca
Novartis
Cutting Edge Laser Technologies
Pfizer
Pierre Fabre
Segment by Type
Medical Therapy
Laser Therapy
Surgery
Other
Segment by Application
Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemangioma companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemangioma Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medical Therapy
1.2.3 Laser Therapy
1.2.4 Surgery
1.2.5 Other
1.3 Market by Application
1.3.1 Global Hemangioma Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Child
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemangioma Market Perspective (2019-2030)
2.2 Hemangioma Growth Trends by Region
2.2.1 Global Hemangioma Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hemangioma Historic Market Size by Region (2019-2024)
2.2.3 Hemangioma Forecasted Market Size by Region (2025-2030)
2.3 Hemangioma Market Dynamics
2.3.1 Hemangioma Industry Trends
2.3.2 Hemangioma Market Drivers
2.3.3 Hemangioma Market Challenges
2.3.4 Hemangioma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemangioma Players by Revenue
3.1.1 Global Top Hemangioma Players by Revenue (2019-2024)
3.1.2 Global Hemangioma Revenue Market Share by Players (2019-2024)
3.2 Global Hemangioma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemangioma Revenue
3.4 Global Hemangioma Market Concentration Ratio
3.4.1 Global Hemangioma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemangioma Revenue in 2023
3.5 Hemangioma Key Players Head office and Area Served
3.6 Key Players Hemangioma Product Solution and Service
3.7 Date of Enter into Hemangioma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemangioma Breakdown Data by Type
4.1 Global Hemangioma Historic Market Size by Type (2019-2024)
4.2 Global Hemangioma Forecasted Market Size by Type (2025-2030)
5 Hemangioma Breakdown Data by Application
5.1 Global Hemangioma Historic Market Size by Application (2019-2024)
5.2 Global Hemangioma Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hemangioma Market Size (2019-2030)
6.2 North America Hemangioma Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hemangioma Market Size by Country (2019-2024)
6.4 North America Hemangioma Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemangioma Market Size (2019-2030)
7.2 Europe Hemangioma Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hemangioma Market Size by Country (2019-2024)
7.4 Europe Hemangioma Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemangioma Market Size (2019-2030)
8.2 Asia-Pacific Hemangioma Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hemangioma Market Size by Region (2019-2024)
8.4 Asia-Pacific Hemangioma Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemangioma Market Size (2019-2030)
9.2 Latin America Hemangioma Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hemangioma Market Size by Country (2019-2024)
9.4 Latin America Hemangioma Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemangioma Market Size (2019-2030)
10.2 Middle East & Africa Hemangioma Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hemangioma Market Size by Country (2019-2024)
10.4 Middle East & Africa Hemangioma Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Akrimax
11.1.1 Akrimax Company Detail
11.1.2 Akrimax Business Overview
11.1.3 Akrimax Hemangioma Introduction
11.1.4 Akrimax Revenue in Hemangioma Business (2019-2024)
11.1.5 Akrimax Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Hemangioma Introduction
11.2.4 AstraZeneca Revenue in Hemangioma Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Hemangioma Introduction
11.3.4 Novartis Revenue in Hemangioma Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Cutting Edge Laser Technologies
11.4.1 Cutting Edge Laser Technologies Company Detail
11.4.2 Cutting Edge Laser Technologies Business Overview
11.4.3 Cutting Edge Laser Technologies Hemangioma Introduction
11.4.4 Cutting Edge Laser Technologies Revenue in Hemangioma Business (2019-2024)
11.4.5 Cutting Edge Laser Technologies Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Hemangioma Introduction
11.5.4 Pfizer Revenue in Hemangioma Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Pierre Fabre
11.6.1 Pierre Fabre Company Detail
11.6.2 Pierre Fabre Business Overview
11.6.3 Pierre Fabre Hemangioma Introduction
11.6.4 Pierre Fabre Revenue in Hemangioma Business (2019-2024)
11.6.5 Pierre Fabre Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
